BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freeman M, Offman J, Walter FM, Sasieni P, Smith SG. Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study. BMJ Open 2017;7:e013901. [PMID: 28255095 DOI: 10.1136/bmjopen-2016-013901] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Anjum MR, Chalmers J, Hamid R, Rajoriya N. COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World J Gastroenterol 2021; 27(44): 7625-7648 [PMID: 34908803 DOI: 10.3748/wjg.v27.i44.7625] [Reference Citation Analysis]
2 Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF. Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge') in the diagnosis of esophageal pathology: a systematic review. Eur J Gastroenterol Hepatol 2018;30:1261-9. [PMID: 30044236 DOI: 10.1097/MEG.0000000000001210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
3 Codipilly DC, Iyer PG. Novel Screening Tests for Barrett's Esophagus. Curr Gastroenterol Rep 2019;21:42. [PMID: 31346777 DOI: 10.1007/s11894-019-0710-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Ireland CJ, Thrift AP, Esterman A. Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study. Dig Dis Sci 2020;65:2992-9. [PMID: 31897894 DOI: 10.1007/s10620-019-06018-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Peters Y, Siersema PD. Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment. Clin Transl Gastroenterol 2020;11:e00260. [PMID: 33105164 DOI: 10.14309/ctg.0000000000000260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
7 O'Donovan M, Fitzgerald RC. Screening for Barrett's Esophagus: Are New High-Volume Methods Feasible? Dig Dis Sci 2018;63:2105-14. [PMID: 29995243 DOI: 10.1007/s10620-018-5192-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol. 2019;17:647-656.e1. [PMID: 30099104 DOI: 10.1016/j.cgh.2018.07.043] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
9 Offman J, Muldrew B, O'Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, Smith SG, Wilson A, Khan Z, Lao-Sirieix P, Aigret B, Walter FM, Rubin G, Morris S, Jackson C, Sasieni P, Fitzgerald RC; BEST3 Trial team. Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer 2018;18:784. [PMID: 30075763 DOI: 10.1186/s12885-018-4664-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
10 Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis 2019;10:2040622319837851. [PMID: 30937155 DOI: 10.1177/2040622319837851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Rosenbaum C, Grimm M, Krause J, Rump A, Kessler R, Hosten N, Weitschies W. Functionality and Acceptance of the EsoCap System-A Novel Film-Based Drug Delivery Technology: Results of an In Vivo Study. Pharmaceutics 2021;13:828. [PMID: 34199636 DOI: 10.3390/pharmaceutics13060828] [Reference Citation Analysis]
12 Guccione C, Yadlapati R, Shah S, Knight R, Curtius K. Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma. Microorganisms 2021;9:2003. [PMID: 34683324 DOI: 10.3390/microorganisms9102003] [Reference Citation Analysis]
13 Kunzmann AT, Thrift AP, Cardwell CR, Lagergren J, Xie S, Johnston BT, Anderson LA, Busby J, Mcmenamin ÚC, Spence AD, Coleman HG. Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma. Clinical Gastroenterology and Hepatology 2018;16:1229-1236.e4. [DOI: 10.1016/j.cgh.2018.03.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
14 Gehrung M, Crispin-Ortuzar M, Berman AG, O'Donovan M, Fitzgerald RC, Markowetz F. Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning. Nat Med 2021;27:833-41. [PMID: 33859411 DOI: 10.1038/s41591-021-01287-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Offman J, Fitzgerald RC. Alternatives to Traditional Per-Oral Endoscopy for Screening. Gastrointest Endosc Clin N Am 2017;27:379-96. [PMID: 28577763 DOI: 10.1016/j.giec.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
16 Feng Y, Liang Y, Yao B, Xu J, Zang J, Zhang Y, Zhang J, Xu G, Wei B, Yao X, Huang P, Shi R. A Rapid Cytological Screening as pre-Endoscopy Screening for Early Esophageal Squamous Cell Lesions: A Prospective Pilot Study from a Chinese Academic Center. Technol Cancer Res Treat 2022;21:15330338211066200. [PMID: 35040718 DOI: 10.1177/15330338211066200] [Reference Citation Analysis]
17 Tan WK, Muldrew B, Khan Z, Fitzgerald RC. A crosssectional analysis of Facebook comments to study public perception of a new diagnostic test called the Cytosponge. Dis Esophagus 2019;32. [PMID: 30239646 DOI: 10.1093/dote/doy085] [Reference Citation Analysis]
18 Davidson M, Chau I. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches. Expert Rev Anticancer Ther 2018;18:327-38. [PMID: 29431018 DOI: 10.1080/14737140.2018.1438271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Krause J, Rosenbaum C, Grimm M, Rump A, Keßler R, Hosten N, Weitschies W. The EsoCap-system - An innovative platform to drug targeting in the esophagus. J Control Release 2020;327:1-7. [PMID: 32781172 DOI: 10.1016/j.jconrel.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]